CORPORATE OVERVIEW

Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease.

LATEST PRESENTATION

JULY 2024

Immunome Corporate Presentation

LATEST EVENTS

5/15/2024

2024 Bank of America Healthcare Conference
Wednesday, May 15 at 10:40am PT

Menu